Germline variants in cancer susceptibility genes among patients with mucosal melanoma.
Saved in:
| Title: | Germline variants in cancer susceptibility genes among patients with mucosal melanoma. |
|---|---|
| Authors: | Amouzegar A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Melanoma and Skin Program, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA, USA., Wu X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Long JP; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chen GW; The Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong JW; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Prabhakaran S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Little L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bota N; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Malke J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Simon J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nagarajan P; Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Oliva ICG; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ikeguchi AP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Su S; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hanna EY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Weiser R; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bednarski B; Department of Colon & Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sims TT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mitra D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wargo J; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Scheet P; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yu Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huff C; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Dr.JMcQuade@gmail.com.; JMQ Oncology Advisors, LLC, Houston, Texas, USA. Dr.JMcQuade@gmail.com., Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. afutreal@mdanderson.org. |
| Source: | NPJ genomic medicine [NPJ Genom Med] 2026 May 23. Date of Electronic Publication: 2026 May 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Center of Excellence in Genomic Medicine Research at King Abdulaziz University Country of Publication: England NLM ID: 101685193 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2056-7944 (Electronic) Linking ISSN: 20567944 NLM ISO Abbreviation: NPJ Genom Med |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
